NCT03440307

Brief Summary

The purpose of this study is to determine whether a 3-week intervention reduces urinary Bisphenol A (BPA) in women with obesity

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 12, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 11, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 22, 2018

Completed
Last Updated

February 22, 2018

Status Verified

February 1, 2018

Enrollment Period

2 years

First QC Date

February 8, 2018

Last Update Submit

February 20, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline Urine BPA at 3-weeks

    Change in urinary BPA measured at baseline and 3-weeks

    Single urine overnight fasted sample at baseline (date of randomization) and 3-weeks

Secondary Outcomes (2)

  • Change from Baseline Urine BPS and BPF at 3-weeks

    Single urine overnight fasted sample at baseline (date of randomization) and 3-weeks

  • Change from Baseline Weight at 3-weeks

    Overnight fasted weight at baseline (date of randomization) and 3-weeks

Study Arms (2)

Email Only

PLACEBO COMPARATOR

Participants received weekly email about health and fitness education. No face-to-face intervention, and not provided any other information about bisphenol exposure.

Behavioral: Email Only

Face-to-Face Meetings

EXPERIMENTAL

Participants met with a counselor once per week for 3-weeks to reduce bisphenol exposure. Intervention included same weekly email about health and fitness education as Email only group, and a weekly face-to-face meetings to reduce bisphenol exposures from food, cosmetics, and packaged products. Women provided with bisphenol-free cosmetics, hygiene, and glass food/water containers.

Behavioral: Face-to-Face Meetings

Interventions

Participants received health and fitness education, and a face-to-face 3-week intervention to reduce bisphenol exposure.

Face-to-Face Meetings
Email OnlyBEHAVIORAL

Participants received health and fitness education.

Email Only

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen have higher BPA vs. Men
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • BMI \>29.9
  • Age 18-50 years
  • Non-smoking
  • English speaking

You may not qualify if:

  • History of infertility
  • Type 2 or Type 1 diabetes
  • Cardiovascular disease, or any other metabolic disease/complication
  • History of major psychiatric illness, drug abuse, or unsafe dieting practices
  • History of bariatric surgery
  • Pregnant women or women expecting or trying to become pregnant
  • Participating in other studies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

California Polytechnic State University

San Luis Obispo, California, 93405, United States

Location

Related Publications (1)

  • Hagobian T, Delli-Bovi Z, Mercado A, Bird A, Guy M, Phelan S. Development and feasibility of randomized trial to reduce urinary bisphenols in women with obesity. Pilot Feasibility Stud. 2021 Jan 12;7(1):24. doi: 10.1186/s40814-020-00744-5.

Study Officials

  • Debbie Hart

    Compliance/Information Officer

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Single-blinded study
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants randomized to intervention or control.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 8, 2018

First Posted

February 22, 2018

Study Start

November 12, 2015

Primary Completion

November 11, 2017

Study Completion

November 11, 2017

Last Updated

February 22, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

No plan to share data in this pilot study

Locations